BioNano Genomics (BNGO) Ownership - Who Owns BioNano Genomics?
BioNano Genomics (BNGO) Ownership Overview
- 0.96% Insiders
- 1.09% Mutual Funds
- <0.01% Other Institutional Investors
- 0.99% ETFs
- 96.95% Public Companies and Individual Investors
The ownership structure of BioNano Genomics (MX:BNGO) stock is a mix of institutional, retail, and individual investors. Approximately 2.09% of the company’s stock is owned by Institutional Investors, 0.96% is owned by Insiders, and 96.95% is owned by Public Companies and Individual Investors.
The ownership structure of BioNano Genomics (MX:BNGO) stock is a mix of institutional, retail, and individual investors. Approximately 2.09% of the company’s stock is owned by Institutional Investors, 0.96% is owned by Insiders, and 96.95% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 08, 2026 | Luderer Albert | $4,840 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 138,786 | Institution | 0.99% | 512,259 |
| Vanguard Index Funds | 82,388 | Institution | 0.59% | 304,094 |
| Fidelity Concord Street Trust | 70,372 | Institution | 0.50% | 259,743 |
| Christopher J. Twomey | 64,500 | Insider | 0.46% | 238,070 |
| David L. Barker | 58,364 | Insider | 0.42% | 215,422 |
| Luderer Albert | 8,000 | Insider | 0.06% | 29,528 |
| Erik Holmlin | 1,657 | Insider | 0.01% | 6,116 |
| Mark Oldakowski | 868 | Insider | <0.01% | 3,204 |
| Alka Chaubey | 620 | Insider | <0.01% | 2,288 |
| Mark Adamchak | 253 | Insider | <0.01% | 934 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 82,388 | Institution | 0.59% | 304,094 |
| Fidelity Concord Street Trust | 70,372 | Institution | 0.50% | 259,743 |
FAQ
Who Owns BioNano Genomics (MX:BNGO)?
According to the latest TipRanks data, approximately 2.09% of the company's stock is held by institutional investors, 0.96% is held by insiders, and 96.95% is held by public companies and individual investors.
What percentage of BioNano Genomics (MX:BNGO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.09% of BioNano Genomics (MX:BNGO) stock is held by institutional investors: 1.09% by mutual funds, 0.99% by ETFs and <0.01% by other institutional investors.
What percentage of BioNano Genomics (MX:BNGO) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.95% of BioNano Genomics (MX:BNGO) stock is held by public companies and individual investors.
Who owns the most shares of BioNano Genomics (MX:BNGO)?
Vanguard owns the most shares of BioNano Genomics (MX:BNGO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.